tiprankstipranks
Advertisement
Advertisement

EVGN Stock Latest News

Evogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
Company AnnouncementsEvogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
8d ago
6K
EVGN
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
PremiumCompany Announcements
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
12d ago
6K
EVGN
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
PremiumThe Fly
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
22d ago
EVGN
Evogene price target lowered to $2.15 from $2.25 at Alliance Global
PremiumThe Fly
Evogene price target lowered to $2.15 from $2.25 at Alliance Global
28d ago
EVGN
Evogene Earnings Call: AI Momentum vs. Cash Strain
PremiumCompany Announcements
Evogene Earnings Call: AI Momentum vs. Cash Strain
1M ago
EVGN
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
PremiumCompany AnnouncementsEvogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
1M ago
6K
EVGN
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
Premium
The Fly
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
1M ago
EVGN
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
Premium
Company Announcements
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
1M ago
6K
EVGN
Evogene price target raised to $2.25 from $1.75 at Alliance Global
PremiumThe Fly
Evogene price target raised to $2.25 from $1.75 at Alliance Global
2M ago
EVGN
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
PremiumCompany Announcements
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
3M ago
6K
EVGN
Evogene receives Nasdaq minimum bid price notification
PremiumThe Fly
Evogene receives Nasdaq minimum bid price notification
3M ago
EVGN
Evogene files to sell 5.08M ordinary shares for holders
PremiumThe Fly
Evogene files to sell 5.08M ordinary shares for holders
3M ago
EVGN
Evogene price target lowered to $1.75 from $2.50 at Alliance Global
PremiumThe FlyEvogene price target lowered to $1.75 from $2.50 at Alliance Global
3M ago
EVGN
Evogene Earnings Call: AI Ambition Meets Cash Reality
Premium
Company Announcements
Evogene Earnings Call: AI Ambition Meets Cash Reality
4M ago
EVGN
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
Premium
Company Announcements
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
4M ago
6K
EVGN
Evogene reports Q4 cont ops EPS (61c) vs. 17c last year
PremiumThe Fly
Evogene reports Q4 cont ops EPS (61c) vs. 17c last year
4M ago
EVGN
EVGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EVGN Earnings this Week: How Will it Perform?
4M ago
EVGN
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
PremiumCompany Announcements
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
4M ago
6K
EVGN
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
PremiumThe Fly
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
4M ago
EVGN
Evogene Secures $3.4 Million Through Warrant Inducement Deal
PremiumCompany AnnouncementsEvogene Secures $3.4 Million Through Warrant Inducement Deal
4M ago
6K
EVGN
Evogene expands collaboration with Google Cloud for AI agents into ChemPass AI
Premium
The Fly
Evogene expands collaboration with Google Cloud for AI agents into ChemPass AI
4M ago
EVGN
GOOG
Evogene, Shanghai Lishan Biopharmaceuticals enter BMC128 licensing agreement
Premium
The Fly
Evogene, Shanghai Lishan Biopharmaceuticals enter BMC128 licensing agreement
5M ago
EVGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >